Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
SYNCHRONIZE-1 hit its co-primary endpoints: 16.6% mean body weight loss at 76 weeks, with up to 85.1% of participants achieving at least 5% weight loss
And beyond gastrointestinal effects, researchers are investigating concerns about long-term impact, such as gallbladder issues, pancreatitis and potential links to thyroid tumors
Withdrawal period N/A Henan Chuangxin Biological Technology Co., Ltd
2005 Jul;48(1):145-51
US$ 23.73
US$ 28.26
US$ 21.87
US$ 21.66
US$ 26.98
US$ 20.48
US$ 22.45
US$ 25.43
